A Triple-drug combination to prevent nausea and vomiting following beam chemotherapy before autologous hematopoietic stem cell transplantation

Transplantation Proceedings

Volumn 43, Issue 8, 2011, Pages 3107-3110

  Pielichowski, W ^a   Barzal, J ^a   Gawronski, K ^a   Mlot, B ^a   Oborska, S ^a   Wasko Grabowska, A ^a   Rzepecki, P ^a  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

APREPITANT; CARMUSTINE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; MELPHALAN; ONDANSETRON; PALONOSETRON;

ACUTE PHASE RESPONSE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; NAUSEA AND VOMITING; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANTIEMETICS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARMUSTINE; CYTARABINE; DEXAMETHASONE; DRUG THERAPY, COMBINATION; ETOPOSIDE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; ISOQUINOLINES; LYMPHOMA, NON-HODGKIN; MALE; MELPHALAN; MORPHOLINES; NAUSEA; ONDANSETRON; QUINUCLIDINES; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VOMITING;

EID: 80054760359     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.08.010     Document Type: Conference Paper

References (16)

1. M.E. Trigg, and D.M. Inverso Nausea and vomiting with high-dose chemotherapy and stem cell rescue therapy: a review of antiemetic regimens Bone Marrow Transplant 42 2008 501
2. S.M. Grunberg, and P.J. Hesketh Control of chemotherapy-induced emesis N Engl J Med 329 1993 1790
3. M.G. Kris, M. Tomnato, and E. Bra Consensus recommendations for the prevention of vomiting and nausea following high-emetic risk chemotherapy Support Care Cancer Suppl 1 2010 S25
4. M.G. Kris, P.J. Hesketh, and M.R. Somerfield American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006 J Clin Oncol 24 2006 2932
5. K. Jordan, I. Kinitz, and W. Voigt Safety and efficacy of a triple antiemetic combination with the NK-1 antagonist aprepitant in highly and moderately emetogenic multiple-day chemotherapy Eur J Cancer 45 2009 1184
6. B. Paul, J.A. Travato, and J. Thompson Efficacy of aprepitant in patients receiving high-dose chemotherapy with hematopoietic cell support J Oncol Pharm Pract 16 2010 45
7. L.A. Bellm, J.B. Epstein, and A. Rose-Ped Patient reports of complications of bone marrow transplantation Support Care Cancer 8 2000 33
8. R.M. Navari Pharmacological management of chemotherapy-induced nausea and vomiting: focus on recent developments Drugs 69 2009 515
9. R.M. Navari Antiemetic control: toward a new standard of care for emetogenic chemotherapy Expert Opin Pharmacother 10 2009 629
10. V. Cocquyt, S. Van Belle, and R.R. Reinhardt Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis Eur J Cancer 37 2001 835
11. S. Van Belle, M.R. Lichinitser, and R.M. Navari Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869 Cancer 94 2002 3032
12. D. Campos, J.R. Pereira, and R.R. Reinhardt Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist, MK-869, in combination with granisetron and dexamethasone or with dexamethasone alone J Clin Oncol 19 2001 1759
13. S.P. Chawla, S.M. Grunberg, and R.J. Gralla Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting Cancer 97 2003 2290
14. J.S. Bubalo, J.F. Leis, and P.T. Curin A double blinded pilot study of aprepitantvs placebo combined with standard antiemetics for the control of nausea and vomiting during hematopoietic cell transplantation Biol Blood Marrow Transplant 13 2007 152
15. J.S. Bubalo, J.F. Leis, and P.T. Curtin A randomized, double-blinded, pilot trial of aprepitant added to standard antiemetics during conditioning therapy for hematopoietic stem cell transplant (HSCT) J Clin Oncol 25 18S 2007 9112
16. R.M. Navari, L.H. Einhorn, and S.D. Passik A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier Oncology Group Study Support Care Cancer 13 2005 529